Peptide Research Library

Epitalon

Main evidence: Community reports. Updated 2026-10-30.

What research and users report, not a recommendation or medical advice. Many of these products are not approved for human use. Ask your doctor. Packs report what sources say, each with its evidence label. A claim labelled community, educator, manufacturer or animal has not been validated in humans.

Summary

This concise pack reports only what the verified community source says and keeps its unvalidated status explicit.

Australian legal status

Australian legal context only: this pack does not make a product-specific Australian legal-status finding for Epitalon. The verified TGA source says that pre-market approval is needed before a therapeutic good can be supplied to the Australian market and that ARTG entry is involved in most cases (tga-supply).

What the sources say

• What it is — The community source describes Epithalon, also called Epitalon, as a synthetic peptide that mimics epithalamin, a polypeptide associated with the pineal gland. This is community material and has not been validated in humans. (Community reports; Epithalon/Epitalon — Research Dosing, 2026-05-16)
• Approval or study status — The community source presents Epithalon/Epitalon as research material and does not document an Australian approved indication. This is community material and has not been validated in humans. (Community reports; Epithalon/Epitalon — Research Dosing, 2026-05-16)
• The community source reports claims concerning telomerase and telomeres for Epithalon/Epitalon. These reports are community material, not validated in humans, and do not establish a clinical benefit. (Community reports; Epithalon/Epitalon — Research Dosing, 2026-05-16)
• The community source lists injection-site reactions such as redness, swelling, or itching. Its safety information is community material and has not been validated in humans. (Community reports; Epithalon/Epitalon — Research Dosing, 2026-05-16)

Sources

1. Epithalon/Epitalon — Research Dosing (2026-05-16)

Dosing, stacking and protocol details are not published here.